Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Choriogonadotropin alfa
Drug ID BADD_D00457
Description Recombinant human chorionic gonadotropin with 2 subunits, alpha = 92 residues, beta = 145 residues, each with N-and O-linked carbohydrate moieties linked to ASN-52 and ASN-78 (on alpha subunit) and ASN-13, ASN-30, SER-121, SER-127, SER-132 and SER-138 (on beta subunit). The primary structure of the alpha-chain of r-hCG is identical to that of the alpha-chain of hCG, FSH and LH.
Indications and Usage For the treatment of female infertility
Marketing Status approved
ATC Code G03GA08
DrugBank ID DB00097
KEGG ID D03478
MeSH ID D006063
PubChem ID Not Available
TTD Drug ID D00TTS
NDC Product Code 50090-5923; 0052-0315; 78206-150; 69443-315; 12860-0315; 44087-1150
UNII 6413W06WR3
Synonyms Chorionic Gonadotropin | Gonadotropin, Chorionic | Choriogonadotropin | Choriogonin | Pregnyl | Chorulon | Gonabion | Biogonadil | Chorionic Gonadotropin, Human | Gonadotropin, Human Chorionic | Human Chorionic Gonadotropin | HCG (Human Chorionic Gonadotropin)
Chemical Information
Molecular Formula Not Available
CAS Registry Number 177073-44-8
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Multiple congenital abnormalities03.02.01.003--Not Available
Mycoplasmal postpartum fever21.14.04.002; 11.10.01.001--Not Available
Nausea07.01.07.001--
Ovarian cyst21.11.01.002; 16.04.03.001--Not Available
Ovarian enlargement21.11.02.001--Not Available
Ovarian hyperstimulation syndrome21.11.02.007; 05.05.01.013--Not Available
Pain08.01.08.004--
Paraesthesia23.03.03.094; 17.02.06.005--
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Premature labour18.07.01.002--Not Available
Pruritus23.03.12.001--
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Thrombocytopenia01.08.01.002--Not Available
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urinary incontinence20.02.02.010; 17.05.01.008--
Urinary tract infection20.08.02.001; 11.01.14.004--
Uterine disorder21.07.01.006--Not Available
Vaginal discharge21.08.02.002--
Vaginal haemorrhage24.07.03.005; 21.08.01.001--
Vaginal infection21.14.02.002; 11.01.10.002--
Vomiting07.01.07.003--
Vulvovaginal discomfort21.08.02.005--Not Available
Affect lability19.04.01.001--Not Available
Hot flush08.01.03.027; 24.03.01.005; 21.02.02.001--
Pulmonary vascular disorder22.06.03.002; 24.03.08.003--Not Available
Ovarian neoplasm21.11.01.005; 16.12.06.001--Not Available
Procedural pain12.02.05.007; 08.01.08.009--Not Available
Adnexal torsion21.11.02.012--Not Available
Haemoperitoneum24.07.02.065; 12.01.17.007; 07.07.02.007--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages